The stock price of Aethlon Medical, Inc. (NASDAQ:AEMD – Get Free Report) broke below its 200-day moving average during trading on Monday. The stock has a 200-day moving average of $1.38 and was trading as low as $0.40. Aethlon Medical shares last traded at $0.42, with a volume of 1,194,305 shares traded.

Wall Street analysts weigh in

Several equities research analysts recently weighed in on AEMD stock. StockNews.com initiated coverage on Aethlon Medical in a report on Sunday, June 23rd. They gave the company a “sell” rating. HC Wainwright lowered their price target on shares of Aethlon Medical from $10.00 to $7.00 and gave the company a “buy” rating in a report on Monday, June 24th.

Read our latest stock analysis on AEMD

Aethlon Medical Stock Return

The company has a 50-day moving average price of $0.68 and a 200-day moving average price of $1.38. The company has a market cap of $1.09 million, a price-to-earnings ratio of -0.09, and a beta of 1.64.

Aethlon Medical (NASDAQ:AEMD – Get Free Report) last released its earnings results on Thursday, June 27. The medical equipment supplier reported ($0.91) EPS for the quarter, beating the consensus estimate of ($1.18) by $0.27. In the same quarter last year, the company earned ($1.10) EPS. Research analysts predict that Aethlon Medical, Inc. will post -5.27 EPS for the current fiscal year.

Company Profile of Aethlon Medical

(Get free report)

Aethlon Medical, Inc., a medical therapeutics company, focuses on developing products to treat cancer and life-threatening infectious diseases in the United States. It is developing Hemopurifier, a clinical-stage immunotherapeutic device that removes tumor-derived exosomes and life-threatening viruses and uses them in organ transplantation.

read more

Get news and reviews for Aethlon Medical Daily – Enter your email address below to receive a concise daily summary of the latest news and analyst ratings on Aethlon Medical and related companies with MarketBeat.com’s FREE daily email newsletter.